Patent · US Active

TRPA1 antagonists

US9751850B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Richard J. Perner · Gurnee, US
Michael E. Kort · Lake Bluff, US
Stanley DiDomenico · Richmond, US
Jun Chen · Lake Bluff, US
Anil Vasudevan · Union Grove, US

Key dates

Filing date	Nov 4, 2014
Grant date	Sep 5, 2017
Priority date	—
Expiry date	Jan 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)wherein R1, R2, R3, and Y are defined in the description are TRPA1 antagonists. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.